Development and validation of an intrinsic capacity score in the UK Biobank study

Abstract

Background

In 2015, the World Health Organization introduced the concept of intrinsic capacity (IC) to define the individual-level characteristics that enable an older person to be and do the things they value. This study developed an intrinsic capacity score for UK Biobank study participants and validated its use as a tool for health outcome prediction, understanding healthy aging trajectories, and genetic research.

Methods

Our analysis included data from 45,208 UK biobank participants who had a complete record of the ten variables included in the analysis. Factor adequacy was tested using Kaiser–Meyer–Olkin, Barthelt's, and the determinant of matrix tests, and the number of factors was determined by the parallel analysis method. Exploratory and confirmatory factor analyses were employed to determine the structure and dimensionality of indicators. Finally, the intrinsic capacity score was generated, and its construct and predictive validities as well as reliability were assessed.

Results

The factor analysis identified a multidimensional construct comprising one general factor (intrinsic capacity) and five specific factors (locomotor, vitality, cognitive, psychological, and sensory). The bifactor structure showed a better fit (comparative fit index = 0.995, Tucker Lewis index = 0.976, root mean square error of approximation = 0.025, root mean square residual = 0.009) than the conventional five-factor structure. The intrinsic capacity score generated using the bifactor confirmatory factor analysis has good construct validity, as demonstrated by an inverse association with age (lower intrinsic capacity in older age; beta = −0.035 (95%CI: −0.036, −0.034)), frailty (lower intrinsic capacity score in prefrail participants, beta = −0.104 (95%CI: (−0.114, −0.094)) and frail participants, beta = −0.227 (95%CI: −0.267, −0.186) than robust participants), and Charlson's comorbidity index for incident cases (a lower intrinsic capacity score associated with increased Charlson's comorbidity index, beta, =−0.019 (95%CI: −0.022, −0.015)). The intrinsic capacity score also predicted incident Charlson's comorbidity index (a one-unit increase in baseline intrinsic capacity score led to a lower Charlson's comorbidity index, beta = 0.147 (95%CI: −0.173, −0.121)) and mortality (a one-unit increase in baseline intrinsic capacity score led to 25 % lower risk of death, odds ratio = 0.75(95%CI: 0.663, 0.848)).

Conclusion

The bifactor structure showed a better fit in all goodness of fit tests. The intrinsic capacity construct has strong structural, construct, and predictive validities and is a promising tool for monitoring aging trajectories.